Gender

Male/Female

Age

Adult

Compensation

Offered

Infectious Diseases

This program provides access to investigational convalescent plasma for hospitalized patients infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.

Male/Female

Age

Adult

Compensation

None

Infectious Diseases

Seeking men and women who are in the hospital and diagnosed with COVID-19 for a study of an investigational drug to see if it acts as an anti-viral and anti-inflammatory treatment for COVID-19 infection.

About

Support

Resources

The UMass Center for Clinical and Translational Science is part of the
Clinical and Translational Science Award (CTSA) program, funded by the
National Center for Advancing Translational Sciences (Grant #
UL1-TR001453) at the National Institutes of Health (NIH).
NIH Citation Requirements

This is an
official Page of
the University of Massachusetts Medical School